We just increased our Investment in ALA - Here’s why
Next Investors Feb 02, 2023
A few weeks ago, a child in the UK received a “base edited” cell therapy for leukaemia. The child went into remission (was cured) within four weeks. We also have an investment in the cell therapy space Arovella Therapeutics (ASX:ALA), that could be cheaper, more readily available, and more effective than existing cell therapy treatments.
EMN Joins an Exclusive Club: EIT InnoEnergy has Entered the Game
Next Investors Feb 23, 2021
This morning one of our our portfolio superstar Euro Manganese Inc (ASX:EMN) just announced that European Union government backed entity EIT Inno Energy will invest €250,000 to fast track EMNs project and also help EMN secure up to €362M to develop EMN’s project.
VN8 Moving up to the Next Tier of ASX Telcos
Next Investors Nov 20, 2020
We added Vonex Ltd (ASX: VN8) to our long term portfolio in September when it was trading at 14 cents per share. We invested because VN8 is not yet well known to ASX investors, but is aspiring to attain a similar valuation to its ASX listed peers: